Relief Therapeutics Holding AG (RLFTF)

[Stratosspace]

<p>COVID-19...if it does not take you out...it is chronic, it is costly!! Remember the mechanism of action: inhibits the virus from replicating itself by blocking the respective receptors (ACE-2) . For example, the influenza virus uses the same ACE-2 receptor to enter the lung cells! Do we need additional Aviptadil clinical trials for the Influenza virus?? Does the Aviptadil market doubles with the influenza virus??</p>
——————

<p> RLF-100(Aviptadil/VIP) has a 30 year research history and is already Approved by some Countries for other Indications (UK Approved for Errectile Dysfunction and EU Orphan drug status for Sarcoidosis treatment *EU designation (EU/3/07/473)), it is already known to be a safe drug with minimal side-effects. </p>

<p> Mechanism Of Action
1. RLF-100 inhibits the SARS-COV-2(COVID19) Virus from replicating itself by blocking the respective receptors. It is the only known Drug so far that prevents the Virus from replicating(spreading), it act's preventive and not just symptomatic.1
2. RLF-100 prevents and/or stops the Cytokine Storm, is highly anti-inflamantory and acts on RANTES (CCL5) - in almost the same way that e.g. CYDY's LL drug does.2
3. RLF-100 is a natural peptide produced and used by the body to protect & heal the lung and to improve blood oxygenation. Severe CASES of COVID-19 have shown low levels of exactly this Peptide.3 </p>

<p> Summary:
RLF-100 blocks the COVID-19 Virus, prevents a cytokine storm, heals the lungs and improves blood oxygenation with a mortality reduction of over 90% in the most severe cases. </p>

<p> RLFTF - the most promising COVID-19 Stock / Drug? - investing
</p>

<p> Pandemics
Seasonal flu, which causes outbreaks every year, should not be confused with pandemic flu, or a global outbreak of a new flu virus that is very different from the strains that typically circulate. This happened in 2009 with the swine flu pandemic, which is estimated to have infected up to 1.4 billion people and killed between 151,000 and 575,000 people worldwide, according to the CDC. There is no flu pandemic happening currently. </p>

https://www.livescience.com/new-coronavirus-compare-with-flu.html

<p> Remember, according to impressive data, RFL-100 inhibits replication by blocking cell entry through ACE2 receptor!! </p>

https://www.the-scientist.com/news-opinion/cells-response-to-sars-cov-2-different-from-flu-rsv-67358

<p> Influenza </p>

<p> According to the World Health Organization, up to five hundred thousand individuals worldwide will die during the typical influenza season each year. A flu pandemic occurs when a new strain of the flu emerges. The worst ever recorded flu pandemic was the Spanish flu in 1918, which killed fifty to 100 million individuals in two years, including individuals in remote locations, such as the Arctic. This unusually deadly pandemic was the first of two influenza pandemics involving the H1N1 strain. Flu vaccines are available now; however, these only cover the most likely strains to appear in a given year, and may not always prevent the flu entirely, though they will shorten the illness and make it less severe should the patient still fall ill.~healthprep </p>

<p> How medical costs pile up </p>

<p> The costs of a hospital bed, health care personnel, medications and potentially the use of medical equipment such as ventilators quickly add up, pushing up the median cost for a person hospitalized to $14,366. </p>

<p> Most COVID-19 patients don’t require hospitalization, so the median cost for any person with symptoms turned out to be $3,045 during the course of the person’s infection. But this is still over four times the typical cost of a symptomatic influenza case and around 5.5 times that of a symptomatic pertussis case. Consider this further evidence that COVID-19 is definitely not “just like the flu.”</p>

<p> Health care costs for the coronavirus don’t end when the patient leaves the hospital. Patients with severe illness may require follow-up visits to the doctor, imaging such as X-rays and CT scans, lab tests, medications or even additional hospitalizations. Those with significant lung damage, for example, may be more susceptible to subsequent infections. </p>

<p> The resulting health care costs over the year after the initial infection raise this median cost per patient by 30% to $3,994. </p>

<p> This shows that you can’t ignore what happens after the initial infection. That would be like walking out of a three-hour movie after just the second hour.
For some patients, the suffering and medical costs don’t end once the virus is no longer present. For example, those who experience lung damage may continue to have breathing problems. Those who managed to survive sepsis and organ failure can have a variety of persistent symptoms. Given these persistent problems, for some, COVID-19 may become more like a chronic condition.
</p>

p> https://local12.com/news/coronavirus/coronavirus-medical-costs-could-be-hundreds-of-billions-as-more-americans-become-infected

<p>

</p>